WallStreetZenWallStreetZen

NASDAQ: ENVB
Enveric Biosciences Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ENVB stock forecasts and price targets.

Forecast return on equity

Is ENVB forecast to generate an efficient return?
Company
-550.79%
Industry
-0.83%
Market
33.94%
ENVB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENVB forecast to generate an efficient return on assets?
Company
-273.96%
Industry
-4.85%
ENVB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENVB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENVB$2.31N/AN/A
PXMD$0.30N/AN/A
JAGX$0.26N/AN/A
GRI$1.69N/AN/A
LIXT$2.19N/AN/A

Enveric Biosciences Stock Forecast FAQ

What is ENVB's forecast return on equity (ROE) for 2023-2023?

(NASDAQ: ENVB) forecast ROE is -550.79%, which is considered weak.

If you're new to stock investing, here's how to buy Enveric Biosciences stock.

What is ENVB's forecast return on assets (ROA) for 2023-2023?

(NASDAQ: ENVB) forecast ROA is -273.96%, which is lower than the forecast US Biotechnology industry average of -4.85%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.